Literature DB >> 8513647

Plasma protein binding and pharmacological response.

P du Souich1, J Verges, S Erill.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8513647     DOI: 10.2165/00003088-199324060-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  19 in total

1.  Influence of changes in protein binding on the central activity of antidepressants.

Authors:  I Torres; E Gomez; E Garcia; E Suárez; J M Rodriguez-Sasiaín; R Calvo
Journal:  J Pharm Pharmacol       Date:  1992-06       Impact factor: 3.765

2.  Abnormal pharmacokinetics of phenytoin in a patient with uraemia.

Authors:  I Odar-Cederlöf; P Lunde; F Sjöqvist
Journal:  Lancet       Date:  1970-10-17       Impact factor: 79.321

3.  Diphenylhydantoin side effects and serum albumin levels.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

Review 4.  Drug protein binding and the nephrotic syndrome.

Authors:  R Gugler; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

5.  Total and free propranolol levels in sensitive and resistant patients.

Authors:  S F Steinberg; J P Bilezikian
Journal:  Clin Pharmacol Ther       Date:  1983-02       Impact factor: 6.875

6.  Plasma protein displacement interactions are rarely of clinical significance.

Authors:  E M Sellers
Journal:  Pharmacology       Date:  1979       Impact factor: 2.547

7.  Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; M D Allen
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

8.  Decrease in penbutolol central response as a cause of changes in its serum protein binding.

Authors:  R Martínez Jordá; C Aguirre; R Calvo; J M Rodríguez-Sasiaín; S Erill
Journal:  J Pharm Pharmacol       Date:  1990-03       Impact factor: 3.765

Review 9.  Resistance to diuretics: emphasis on a pharmacological perspective.

Authors:  D C Brater
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

10.  Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.

Authors:  F M Belpaire; M G Bogaert; P Mugabo; M T Rosseel
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

View more
  11 in total

Review 1.  What is the true clinical significance of plasma protein binding displacement interactions?

Authors:  L N Sansom; A M Evans
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

2.  An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.

Authors:  J H Proost; J M Wierda; D K Meijer
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

3.  Unexpected relationship between plasma protein binding and the pharmacodynamics of 2-NAP, a CCK1-receptor antagonist.

Authors:  V P Gerskowitch; J Hodge; R A D Hull; N P Shankley; S B Kalindjian; J McEwen; J W Black
Journal:  Br J Clin Pharmacol       Date:  2006-10-17       Impact factor: 4.335

4.  Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing.

Authors:  J Lipman; S C Wallis; C Rickard
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Differential effect of cancer on the serum protein binding to mianserin and imipramine.

Authors:  I Torres; E Suárez; J M Rodríguez-Sasiain; C Aguirre; R Calvo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Apr-Jun       Impact factor: 2.441

Review 6.  Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.

Authors:  M Barry; S Gibbons; D Back; F Mulcahy
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

Review 7.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Factors affecting variability in distribution of tacrolimus in liver transplant recipients.

Authors:  H Zahir; G McCaughan; M Gleeson; R A Nand; A J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

9.  Influence of serum protein binding on the in vitro activity of anti-fungal agents.

Authors:  M Schäfer-Korting; H C Korting; W Rittler; W Obermüller
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

10.  Stability of the Hsp90 inhibitor 17AAG hydroquinone and prevention of metal-catalyzed oxidation.

Authors:  Wenchang Guo; David Siegel; David Ross
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.